Literature DB >> 12756132

Subthalamic stimulation in Parkinson disease: intraoperative predictive factors.

Jean-Luc Houeto1, Marie-Laure Welter, Paul-Boulos Bejjani, Sophie Tezenas du Montcel, Anne-Marie Bonnet, Valerie Mesnage, Soledad Navarro, Bernard Pidoux, Didier Dormont, Philippe Cornu, Yves Agid.   

Abstract

BACKGROUND: High-frequency stimulation of the subthalamic nucleus (STN) is an effective treatment for advanced forms of Parkinson disease. Postoperative improvement of motor parkinsonian disability is known to depend on patient selection and surgical targeting.
OBJECTIVE: To determine which clinical and electrophysiological variables evaluated during the operation predict the postoperative clinical outcome of patients with Parkinson disease treated by bilateral high-frequency stimulation of the STN.
METHODS: Intraoperative clinical and electrophysiological data obtained in 41 patients with Parkinson disease who underwent bilateral implantation of electrodes for STN stimulation were correlated with the improvement in parkinsonian disability assessed 6 months after the operation.
RESULTS: The extent of STN neuronal activity recorded along the trajectory of the therapeutic electrode had no effect on the postoperative clinical outcome. The intraoperative improvement in segmental akinesia, but not rigidity, was predictive of the postoperative improvement in parkinsonian motor disability and reduction in daily levodopa-equivalent dosage. Parkinsonian motor disability scores assessed after surgery were lower in patients with intraoperative stimulation-induced dyskinesias than in those without stimulation-induced dyskinesias.
CONCLUSION: The improvement of segmental akinesia and the observation of dyskinesias provoked by stimulation during the operation predict the best postoperative effects of bilateral STN stimulation on parkinsonian motor disability.

Entities:  

Mesh:

Year:  2003        PMID: 12756132     DOI: 10.1001/archneur.60.5.690

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.

Authors:  W M M Schüpbach; N Chastan; M L Welter; J L Houeto; V Mesnage; A M Bonnet; V Czernecki; D Maltête; A Hartmann; L Mallet; B Pidoux; D Dormont; S Navarro; P Cornu; A Mallet; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

Review 2.  Deep brain stimulation (DBS) at the interface of neurology and psychiatry.

Authors:  Nolan R Williams; Michael S Okun
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

3.  Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease.

Authors:  T Hershey; J Wu; P M Weaver; D C Perantie; M Karimi; S D Tabbal; J S Perlmutter
Journal:  Exp Neurol       Date:  2007-11-29       Impact factor: 5.330

4.  Bilateral Deep Brain Stimulation of the Subthalamic Nucleus under Sedation with Propofol and Fentanyl.

Authors:  Woong-Woo Lee; Gwanhee Ehm; Hui-Jun Yang; In Ho Song; Yong Hoon Lim; Mi-Ryoung Kim; Young Eun Kim; Jae Ha Hwang; Hye Ran Park; Jae Min Lee; Jin Wook Kim; Han-Joon Kim; Cheolyoung Kim; Hee Chan Kim; Eunkyoung Park; In Young Kim; Dong Gyu Kim; Beomseok Jeon; Sun Ha Paek
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

5.  Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.

Authors:  Ji Hee Kim; Won Seok Chang; Hyun Ho Jung; Jin Woo Chang
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

6.  Optimal target localization for subthalamic stimulation in patients with Parkinson disease.

Authors:  Marie-Laure Welter; Michael Schüpbach; Virginie Czernecki; Carine Karachi; Sara Fernandez-Vidal; Jean-Louis Golmard; Giulia Serra; Soledad Navarro; Arlette Welaratne; Andréas Hartmann; Valérie Mesnage; Fanny Pineau; Philippe Cornu; Bernard Pidoux; Yulia Worbe; Panayiotis Zikos; David Grabli; Damien Galanaud; Anne-Marie Bonnet; Hayat Belaid; Didier Dormont; Marie Vidailhet; Luc Mallet; Jean-Luc Houeto; Eric Bardinet; Jerome Yelnik; Yves Agid
Journal:  Neurology       Date:  2014-03-19       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.